Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Financing, Personal | 2 | 2023 | 309 | 1.390 |
Why?
|
Health Care Sector | 2 | 2024 | 196 | 0.840 |
Why?
|
Emigration and Immigration | 2 | 2022 | 395 | 0.780 |
Why?
|
Private Sector | 1 | 2024 | 397 | 0.740 |
Why?
|
Thyroid Neoplasms | 3 | 2023 | 2332 | 0.720 |
Why?
|
Physicians, Family | 1 | 2022 | 349 | 0.690 |
Why?
|
Family Practice | 1 | 2022 | 510 | 0.660 |
Why?
|
Emergency Medical Technicians | 1 | 2019 | 118 | 0.630 |
Why?
|
Commerce | 1 | 2024 | 605 | 0.630 |
Why?
|
Emigrants and Immigrants | 2 | 2022 | 539 | 0.610 |
Why?
|
Capacity Building | 1 | 2019 | 257 | 0.560 |
Why?
|
Marketing | 3 | 2023 | 220 | 0.520 |
Why?
|
Thyroid Nodule | 1 | 2023 | 760 | 0.510 |
Why?
|
Career Choice | 1 | 2021 | 754 | 0.500 |
Why?
|
Physicians | 2 | 2023 | 4591 | 0.480 |
Why?
|
Osteoarthritis, Knee | 1 | 2023 | 1234 | 0.420 |
Why?
|
Health Expenditures | 1 | 2023 | 2362 | 0.370 |
Why?
|
Students, Medical | 2 | 2020 | 1927 | 0.330 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 2138 | 0.330 |
Why?
|
Public Health | 2 | 2021 | 2653 | 0.320 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3763 | 0.300 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5325 | 0.300 |
Why?
|
Emergency Medical Services | 1 | 2019 | 1925 | 0.300 |
Why?
|
Capital Financing | 2 | 2023 | 59 | 0.250 |
Why?
|
Public Sector | 1 | 2024 | 265 | 0.200 |
Why?
|
Injections, Intra-Articular | 1 | 2023 | 279 | 0.200 |
Why?
|
Florida | 1 | 2022 | 430 | 0.180 |
Why?
|
Accreditation | 1 | 2024 | 477 | 0.180 |
Why?
|
United States | 9 | 2024 | 72461 | 0.180 |
Why?
|
Insurance | 1 | 2021 | 114 | 0.170 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 482 | 0.170 |
Why?
|
Biotechnology | 1 | 2021 | 281 | 0.170 |
Why?
|
Ambulances | 1 | 2019 | 92 | 0.160 |
Why?
|
Urology | 1 | 2023 | 423 | 0.150 |
Why?
|
Hospitals, Teaching | 1 | 2022 | 1166 | 0.150 |
Why?
|
Drug Industry | 1 | 2023 | 789 | 0.140 |
Why?
|
Ophthalmology | 1 | 2021 | 549 | 0.120 |
Why?
|
Humans | 20 | 2024 | 760621 | 0.120 |
Why?
|
Pandemics | 3 | 2022 | 8624 | 0.110 |
Why?
|
Cost of Illness | 1 | 2022 | 1940 | 0.100 |
Why?
|
Investments | 2 | 2023 | 148 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2023 | 80372 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1727 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5397 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9411 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10551 | 0.070 |
Why?
|
Nanoparticles | 1 | 2018 | 1943 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3600 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2477 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6786 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
United States Government Agencies | 1 | 2021 | 26 | 0.050 |
Why?
|
Dextroamphetamine | 1 | 2021 | 134 | 0.050 |
Why?
|
Amphetamines | 1 | 2021 | 143 | 0.050 |
Why?
|
Public-Private Sector Partnerships | 1 | 2021 | 122 | 0.050 |
Why?
|
Bupropion | 1 | 2021 | 304 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 415 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54303 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 730 | 0.030 |
Why?
|
Complement Activation | 1 | 2018 | 446 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 553 | 0.030 |
Why?
|
Managed Care Programs | 1 | 2021 | 939 | 0.030 |
Why?
|
Hemostasis | 1 | 2018 | 468 | 0.030 |
Why?
|
Hemostatics | 1 | 2018 | 243 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1091 | 0.030 |
Why?
|
Universities | 1 | 2020 | 992 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22072 | 0.030 |
Why?
|
Vasodilation | 1 | 2018 | 962 | 0.030 |
Why?
|
Models, Animal | 1 | 2018 | 2117 | 0.020 |
Why?
|
Aged | 1 | 2023 | 169152 | 0.020 |
Why?
|
Swine | 1 | 2018 | 5899 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9280 | 0.020 |
Why?
|
Male | 2 | 2022 | 359744 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11152 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3701 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3388 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15687 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4744 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42063 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41335 | 0.010 |
Why?
|
Child | 1 | 2021 | 79806 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 87810 | 0.010 |
Why?
|
Adult | 1 | 2021 | 219994 | 0.000 |
Why?
|
Animals | 1 | 2018 | 167963 | 0.000 |
Why?
|
Female | 1 | 2021 | 391270 | 0.000 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_